|
340 Transplant Proc, 2003, 35(1): 443-444. [19] Xu A S, Reid L M. Soft, porous poly(D,L-lactide-co-glycotide) microcarriers designed for ex vivo studies and for transplantation of adherent cell types including progenitors[J]. Ann N Y Acad Sci, 2001, 944: 144-159. [20] Werner A, Duvar S, Muthing J, Buntemeyer H, Lunsdorf H, Strauss M, Lehmann J. Cultivation of immortalized human hepatocytes HepZ on macroporous CultiSpher G microcarriers[J]. Biotechnol Bioeng, 2000, 345 68(1): 59-70. [21] Xu Q, Yu D, Qiu Y, Zhang H, Ding Y. Function of a new internal bioartificial liver: an in vitro study[J]. Ann Clin Lab Sci, 2003, 33(3): 306-312. [22] Suh K S, Lilja H, Kamohara Y, Eguchi S, Arkadopoulos N, Neuman T, Demetriou A A, Rozga J. Bioartificial liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver-enriched and 350 growth-associated transcription factors[J]. J Surg Res, 1999, 85(2): 243-250. [23] Naruse K, Tang W, Makuuch M. Artificial and bioartificial liver support: a review of perfusion treatment for hepatic failure patients[J]. World J Gastroenterol, 2007, 13(10): 1516-1521. [24] Iwahori T, Matsuno N, Johjima Y, Konno O, Akashi I, Nakamura Y, Hama K, Iwamoto H, Uchiyama M, Ashizawa T, Nagao T. Radial flow bioreactor for the creation of bioartificial liver and kidney[J]. Transplant Proc, 355 2005, 37(1): 212-214. [25] Sussman N L, Gislason G T, Conlin C A, Kelly J H. The Hepatix extracorporeal liver assist device: initial clinical experience[J]. Artif Organs, 1994, 18(5): 390-396. [26] Peng C H, Han B S, Gao C Y, Ma Z W, Zhao Z M, Wang Y, Liu H, Zhang G D, Yang M J. Study on the interface of human hepatocyte/micropore polypropylene ultrafiltration membrane[J]. Zhonghua Yi Xue Za Zhi, 360 2004, 84(17): 1460-1464. [27] De Bartolo L, Salerno S, Curcio E, Piscioneri A, Rende M, Morelli S, Tasselli F, Bader A, Drioli E. Human hepatocyte functions in a crossed hollow fiber membrane bioreactor[J]. Biomaterials, 2009, 30(13): 2531-2543. [28] Pazzi P, Morsiani E, Vilei M T, Granato A, Rozga J, Demetriou A A, Muraca M. Serum bile acids in patients with liver failure supported with a bioartificial liver[J]. Aliment Pharmacol Ther, 2002, 16(8): 1547-1554. 365 [29] Gao Y, Mu N, Xu X P, Wang Y. Porcine acute liver failure model established by two-phase surgery and treated with hollow fiber bioartificial liver support system[J]. World J Gastroenterol, 2005, 11(35): 5468-5474. [30] Morsiani E, Pazzi P, Moscioni A D, Rozga J, Azzena G, Demetriou A A. In vitro morphological and functional characterization of isolated porcine hepatocytes for extracorporeal liver support: bile acid uptake and conjugation[J]. J Surg Res, 1998, 79(1): 54-60. 370 [31] Chamuleau R A, Poyck P P, van de Kerkhove M P. Bioartificial liver: its pros and cons[J]. Ther Apher Dial, 2006, 10(2): 168-174. [32] Jauregui H O, Naik S, Santangini H A, Trenkler D M, Mullon C J-P. The use of microcarrier-roller bottle culture for large-scale production of porcine hepatocytes[J]. Tissue Engineering, 1997, 3(1): 17-25. [33] Donato M T, Castell J V, Gomez-Lechon M J. Characterization of drug metabolizing activities in pig 375 hepatocytes for use in bioartificial liver devices: comparison with other hepatic cellular models[J]. J Hepatol, 1999, 31(3): 542-549. [34] Ehashi T, Ohshima N, Miyoshi H. Three-dimensional culture of porcine fetal liver cells for a bioartificial liver[J]. J Biomed Mater Res A, 2006, 77(1): 90-96. [35] Kawashita Y, Ohtsuru A, Fujioka H, Kamohara Y, Kawazoe Y, Sugiyama N, Eguchi S, Kuroda H, Furui J, 380 Yamashita S, Kaneda Y, Kanematsu T. Safe and efficient gene transfer into porcine hepatocytes using Sendai virus-cationic liposomes for bioartificial liver support[J]. Artif Organs, 2000, 24(12): 932-938. [36] Schrem H, Kleine M, Borlak J, Klempnauer J. Physiological incompatibilities of porcine hepatocytes for clinical liver support[J]. Liver Transpl, 2006, 12(12): 1832-1840. [37] Sharma R, Greenhough S, Medine C N, Hay D C. Three-dimensional culture of human embryonic stem cell derived hepatic endoderm and its role in bioartificial liver construction[J]. J Biomed Biotechnol, 2010, 2010: 236147. [38] Kobayashi N. Life support of artificial liver: development of a bioartificial liver to treat liver failure[J]. J Hepatobiliary Pancreat Surg, 2009, 16(2): 113-117. [39] Omasa T, Kim K, Hiramatsu S, Katakura Y, Kishimoto M, Enosawa S, Ohtake H. Construction and evaluation of drug-metabolizing cell line for bioartificial liver support system[J]. Biotechnol Prog, 2005, 21(1): 161-167. [40] Wen F, Chang S, Toh Y C, Arooz T, Zhuo L, Teoh S H, Yu H. Development of dual-compartment perfusion bioreactor for serial coculture of hepatocytes and stellate cells in poly(lactic-co-glycolic acid)-collagen scaffolds[J]. J Biomed Mater Res B Appl Biomater, 2008, 87(1): 154-162. [41] Chamuleau R A, Deurholt T, Hoekstra R. Which are the right cells to be used in a bioartificial liver?[J]. Metab Brain Dis, 2005, 20(4): 327-335. 学术论文网Tag： |
